[On Demand]

SilcsBio provides computer-aided drug design solutions that dramatically accelerate and improve small molecule and biologic drug discovery pipelines. Our experts provide consultation and training, paired with guided deployment of the SILCS platform technology, to enable drug discovery teams to work faster and more productively. Our proprietary CADD software technology, SILCS, allows researchers to visualize and interact with 3D maps of protein surfaces for drug design. Compared to other computer-aided drug discovery softwares that use static structure for their models, we take advantage of dynamic conformations of protein targets in physiological condition. This allows us to unlock potentially hidden state that is not accessible from static structure model. Our patented platform technology can screen more than 1 billion compounds quickly as we utilize interactions in grid representation.


SilcsBio is presenting as part of the NIH Innovation Zone.

Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Director of Commercial Development